000 | 01186 a2200325 4500 | ||
---|---|---|---|
005 | 20250517183734.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.19085 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJoshi, Avadhut D | |
245 | 0 | 0 |
_aSynergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients. _h[electronic resource] |
260 |
_bOncotarget _cOct 2017 |
||
300 |
_a80124-80138 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aBotham, Rachel C | |
700 | 1 | _aSchlein, Lisa J | |
700 | 1 | _aRoth, Howard S | |
700 | 1 | _aMangraviti, Antonella | |
700 | 1 | _aBorodovsky, Alexandra | |
700 | 1 | _aTyler, Betty | |
700 | 1 | _aJoslyn, Steve | |
700 | 1 | _aLooper, Jayme S | |
700 | 1 | _aPodell, Michael | |
700 | 1 | _aFan, Timothy M | |
700 | 1 | _aHergenrother, Paul J | |
700 | 1 | _aRiggins, Gregory J | |
773 | 0 |
_tOncotarget _gvol. 8 _gno. 46 _gp. 80124-80138 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.19085 _zAvailable from publisher's website |
999 |
_c27764197 _d27764197 |